Clopidogrel Bisulphate is indicated to reduce risk of cardiovascular disorders and stroke. It is a kind of antiplatelet medicine which prevents clotting of blood in veins & arteries. This compound is known to work by inhibiting activity of P2Y12 which is known to be the subtype of ADP receptor. It has bioavailability of about 50% with protein binding ability of 94 to 98%. After ingestion, this compound takes about 2 hours for exerting its action. It gets metabolized in liver with elimination half life of about 7 to 8 hours. Metabolism of Clopidogrel Bisulphate is done by CYP2C19, CYP1A2, and CYP2B6.